Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

Inclusion Criteria:

• Patients who are admitted to Advanced Care at Home (ACH) Program and supposed toremain in ACH for at least 72 hours.

• Patients with previous diagnosis of DM type 1 or type 2.

• Patients taking subcutaneous (SQ) insulin either via multidose injections or SQinsulin pump.

• Capable of giving signed informed consent

Exclusion Criteria:

• Actively treated for diabetes ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).

• Participants taking acetaminophen more than 4g per day or more than 1gm every 6hours.

• Participants with altered mental status.

• Participants diagnosed with dementia.

• Patients with suicidal ideations or experiencing suicidal behavior.

• Patients with liver cirrhosis.

• Patients with End Stage Renal Disease on dialysis bot hemodialysis or peritonealdialysis.

• Participants with allergy to medical grade adhesive or medical tape.

• Participants taking hydroxyurea.

• Participants who are pregnant, wanting to become pregnant, or nursing during studyperiod.

• Patients with a planned MRI within the following 10 days after admission to ACH.

• Participants currently using continuous glucose monitor (CGM) to dose insulin orcheck glucose level.

• Participants with diabetes mellitus (DM) treated with diet alone.

• Participants with DM treated with oral hypoglycemic medications.

• Participants with DM treated with one SQ insulin injection daily.

• Participants enrolled in other studies addressing CGM use.

• Participants physically or emotionally incapable of handling a cell phone with asmart display.

• Participants with hearing impaired to a degree that they are not able to hear asmart phone alert or alarm.

• Patients lacking WIFI or Cellular coverage needed to connect the monitoring cellphone to Internet network.